|Publication status||Published - 1 Jul 2019|
|Event||5th Congress of the European Academy of Neurology - Oslo, Norway|
Duration: 29 Jun 2019 → 2 Jul 2019
|Conference||5th Congress of the European Academy of Neurology|
|Period||29/06/2019 → 02/07/2019|
Schoonheim, MM., Jonkman, LE., Eijlers, AJC., Meijer, KA., Killestein, J., & Geurts, JJG. (2019). Long-term natalizumab treatment is associated with a reduction in lesional white matter levels of myo-inostiol, a biomarker of gliotic activity. Poster session presented at 5th Congress of the European Academy of Neurology, Oslo, Norway.